We serve N-Boc-L-valine methyl ester CAS:58561-04-9 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name: methyl (2S)-3-methyl-2-[(2-methylpropan-2-yl)oxycarbonylamino]butanoate
CAS.NO: 58561-04-9
Molecular Formula:C11H21NO4
Molecular Weight: 231.28900
Synonyms:
BOC VALINE METHYLESTER
Boc-L-Val-OMe
N-Boc-L-valine methyl ester
MFCD00672510
N-t-butoxycarbonyl-L-valine methyl ester
Boc-Val-OMe
N-Boc-L-Val-OMe
Boc-L-valine methyl ester
Physical and Chemical Properties:
Density: 1.02g / cm3
Boiling point: 306ºC at 760mmHg
Melting point: 194 ° C
Flash point: 138.9ºC
Refractive index: n20 / D 1.44 (lit.)
Specification:
Appearance: White powder
Purity:≥98%
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Keep the container tightly closed, put it in a tight dispenser, and store in a cool, dry place.
Application:pharmaceutical intermediates.
Contact us for information like methyl (2S)-3-methyl-2-[(2-methylpropan-2-yl)oxycarbonylamino]butanoate chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Boc-L-valine methyl ester physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,MFCD00672510 Use and application,MFCD00672510 technical grade,usp/ep/jp grade.
Related News: U.S. drugmaker Gilead dominates the HIV market and it will keep up the pressure with fast-growing Biktarvy, which was approved early last year.2-chloro-4-(piperidin-1-ylmethyl)pyridine,oxalic acid manufacturer U.S. drugmaker Gilead dominates the HIV market and it will keep up the pressure with fast-growing Biktarvy, which was approved early last year.3-chloro-4-(pyridin-2-ylmethoxy)aniline supplier With the speeding up of review and approval, the number of approved innovative drugs in China is about to usher in a year of blowout.5-tert-butyl-1,2-dihydro-1,2,4-triazole-3-thione vendor With the speeding up of review and approval, the number of approved innovative drugs in China is about to usher in a year of blowout.The Company has established a leadership position in the clinical development and manufacture of universal, off-the-shelf cell products using its proprietary induced pluripotent stem cell (iPSC) product platform.
